2050 Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
42
- Portfolio
-
23
- Exits
-
17
2050 Capital General Information
Company Description
Founded in 2015, 2050 Capital is a venture capital firm based in London, United Kingdom. The firm seeks to invest in enterprise software companies operating in industrials & manufacturing, healthcare, communication & data management, computational biotech, defense & aerospace, engineering, construction, clean energy, mobility, science ventures, agriculture, and financial services sectors across the United Kingdom, Europe, the United States, and Asia.
Business Details
Website
www.2050cap.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Fourth Floor
- 41 Dover Street
- London W1S 4NR
- England, United Kingdom
2050 Capital Investments (42)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| OSCP (Application Specific Semiconductors) | 01-Sep-2026 | Later Stage VC | Application Specific Semiconductors | Generating Revenue | ||
| Origin (Diagnostic Equipment) | 23-Dec-2024 | Diagnostic Equipment | Generating Revenue | |||
| Blackrock Neurotech | 31-Jul-2023 | Therapeutic Devices | Generating Revenue | |||
| KETS | 01-Jul-2023 | Application Specific Semiconductors | Generating Revenue | |||
| OSCP (Application Specific Semiconductors) | 20-Jun-2023 | Application Specific Semiconductors | Generating Revenue | |||
| ChAI | 14-Oct-2022 | Business/Productivity Software | Generating Revenue | |||
| Hadean | 23-Sep-2022 | Software Development Applications | Generating Revenue | |||
| Biofourmis | 27-Jul-2022 | Decision/Risk Analysis | Generating Revenue | |||
| Paradromics | 01-Apr-2022 | Seed Round | Other Healthcare Technology Systems | Pre-Clinical Trials | ||
| Neuroglee Health | 03-Dec-2020 | Seed Round | Therapeutic Devices | Generating Revenue |
2050 Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Konsileo | 01-Sep-2026 | Secondary Transaction - Private | |
| WealthKernel | 06-Mar-2026 | ||
| Aquant | 01-Mar-2026 | ||
| Snyk | 01-Mar-2026 | ||
| Mekanys | 01-Feb-2025 | ||
| Winimy | 01-Feb-2025 | ||
| Biofourmis | 17-Sep-2024 | ||
| Goldex | 02-Jul-2024 | ||
| Car Quids | 14-May-2024 | Out of Business | |
| Vauban (Financial Software) | 29-Jun-2022 | Merger/Acquisition |
2050 Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
2050 Capital Co-Investors (69)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| CSVE Ventures | 2 |
|
|
||
| Plug and Play |
|
|
|||
| What If Ventures |
|
|
|||
| General Atlantic |
|
|
|||
| In-Q-Tel |
|
|
2050 Capital FAQs
-
What is 2050 Capital?
Founded in 2015, 2050 Capital is a venture capital firm based in London, United Kingdom.
-
When was 2050 Capital founded?
2050 Capital was founded in 2015.
-
Where is 2050 Capital headquartered?
2050 Capital is headquartered in London, United Kingdom.
-
How many investments has 2050 Capital made?
2050 Capital has made 42 investments.
-
What has 2050 Capital invested in?
2050 Capital has made numerous investments in companies like OSCP (Application Specific Semiconductors), Origin (Diagnostic Equipment), and Blackrock Neurotech within the Application Specific Semiconductors, Diagnostic Equipment, and Therapeutic Devices industries.
-
What has 2050 Capital invested in recently?
2050 Capital's latest investment was on 01-Sep-2026 in OSCP (Application Specific Semiconductors), a company within the Application Specific Semiconductors industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
